Fullerton Fund Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Fullerton Fund Management's LLY Position: Q2 2026 in Review
Fullerton Fund Management increased its Eli Lilly (LLY) stake by 57% in Q2 2026, buying an estimated $661K and bringing the position to 1,784 shares worth $2.14M. The position accounts for 0.14% of the portfolio, ranked #33.
Fullerton Fund Management first reported a position in LLY in Q3 2022 and has held it in 16 quarters since. The position peaked at $48.4M in Q2 2024. 4,635 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Fullerton Fund Management held 1,784 shares of Eli Lilly worth $2.14M as of Q2 2026.
- Fullerton Fund Management bought 647 Eli Lilly shares in Q2 2026, an estimated $661K.
- Eli Lilly made up 0.14% of Fullerton Fund Management's portfolio in Q2 2026, its #33 holding.
- Fullerton Fund Management first reported a position in Eli Lilly in Q3 2022 and has held it in 16 quarters since.
- Fullerton Fund Management's Eli Lilly position peaked at $48.4M in Q2 2024.
- 4,635 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Fullerton Fund Management's 13F filing for Q2 2026, filed 14 Aug 2026.